Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Healthy
Interventions
DRUG

ALO-01

ALO-01 capsules

DRUG

MSIR

immediate release morphine sulfate

DRUG

Placebo

Placebo

Trial Locations (1)

M5V 2T3

DecisionLine Clinical Research, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY